Cardiac contractility modulation for patient with refractory heart failure: an updated evidence-based review

[1]  M. Metra,et al.  THE INTERPLAY BETWEEN CARDIOLOGY AND DIABETOLOGY: A RENEWED COLLABORATION TO OPTIMIZE CARDIOVASCULAR PREVENTION AND HEART FAILURE MANAGEMENT. , 2020, European heart journal. Cardiovascular pharmacotherapy.

[2]  G. Niccoli,et al.  Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence. , 2020, Progress in cardiovascular diseases.

[3]  D. Burkhoff,et al.  Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System , 2020, Circulation. Heart failure.

[4]  P. Ponikowski,et al.  Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. , 2020, The New England journal of medicine.

[5]  W. Abraham,et al.  Optimizer smart in the treatment of moderate-to-severe chronic heart failure. , 2019, Future cardiology.

[6]  D. Burkhoff,et al.  Cost‐effectiveness of a cardiac contractility modulation device in heart failure with normal QRS duration , 2019, ESC heart failure.

[7]  D. DeMets,et al.  Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction , 2019, Circulation.

[8]  P. Ponikowski,et al.  Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology , 2019, European journal of heart failure.

[9]  A. Goette,et al.  Cardiac contractility modulation improves long‐term survival and hospitalizations in heart failure with reduced ejection fraction , 2019, European journal of heart failure.

[10]  D. Burkhoff,et al.  Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT). , 2019, International journal of cardiology.

[11]  D. Burkhoff,et al.  Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond , 2018, European journal of heart failure.

[12]  D. Burkhoff,et al.  A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. , 2018, JACC. Heart failure.

[13]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[14]  T. Lawo,et al.  Long-term survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration. , 2016, International journal of cardiology.

[15]  W. Linke,et al.  Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF. , 2016, International journal of cardiology.

[16]  D. Burkhoff,et al.  Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients. , 2015, International journal of cardiology.

[17]  T. Lüscher.  Heart failure: the cardiovascular epidemic of the 21st century. , 2015, European heart journal.

[18]  Mark D. Huffman,et al.  AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .

[19]  D. Burkhoff,et al.  A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design. , 2015, Journal of cardiac failure.

[20]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[21]  M. Piepoli,et al.  Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials. , 2014, International journal of cardiology.

[22]  William T. Abraham,et al.  Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex , 2013 .

[23]  D. Feldman,et al.  Cardiac contractility modulation therapy in advanced systolic heart failure , 2013, Nature Reviews Cardiology.

[24]  L. Lund,et al.  Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. , 2013, European heart journal.

[25]  D. Burkhoff,et al.  Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure , 2012, European journal of heart failure.

[26]  M. Cannell,et al.  Local control in cardiac E-C coupling. , 2012, Journal of molecular and cellular cardiology.

[27]  D. Burkhoff,et al.  Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. , 2011, Journal of cardiac failure.

[28]  G. Ng,et al.  Cardiac contractility modulation in the treatment of heart failure: initial results and unanswered questions , 2011, European journal of heart failure.

[29]  D. Burkhoff,et al.  A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. , 2011, American heart journal.

[30]  Michael Böhm,et al.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.

[31]  D. Burkhoff,et al.  Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. , 2009, JACC. Cardiovascular imaging.

[32]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[33]  H. Nägele,et al.  Cardiac contractility modulation in non-responders to cardiac resynchronization therapy. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[34]  D. Burkhoff,et al.  A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. , 2008, American heart journal.

[35]  D. Burkhoff,et al.  Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. , 2008, Journal of the American College of Cardiology.

[36]  G. Hindricks,et al.  Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. , 2008, European heart journal.

[37]  H. Sabbah,et al.  Effects of Chronic Therapy with Cardiac Contractility Modulation Electrical Signals on Cytoskeletal Proteins and Matrix Metalloproteinases in Dogs with Heart Failure , 2007, Cardiology.

[38]  D. Burkhoff,et al.  Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. , 2007, Journal of the American College of Cardiology.

[39]  D. Burkhoff,et al.  Nonexcitatory, cardiac contractility modulation electrical impulses: Feasibility study for advanced heart failure in patients with normal QRS duration , 2006 .

[40]  D. Burkhoff,et al.  Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration. , 2006, Heart rhythm.

[41]  D. Burkhoff,et al.  Cardiac contractility modulation by non‐excitatory currents: Studies in isolated cardiac muscle , 2006, European journal of heart failure.

[42]  G. Hindricks,et al.  Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration. , 2005, Journal of the American College of Cardiology.

[43]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[44]  D. Burkhoff,et al.  Electric Currents Applied During the Refractory Period Can Modulate Cardiac Contractility In Vitro and In Vivo , 2004, Heart Failure Reviews.

[45]  D. Burkhoff,et al.  Electric currents applied during refractory period enhance contractility and systolic calcium in the ferret heart. , 2003, American journal of physiology. Heart and circulatory physiology.

[46]  S. Ben‐Haim,et al.  Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. , 2003, Journal of cardiac failure.

[47]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[48]  D. Bers.  Cardiac excitation–contraction coupling , 2002, Nature.

[49]  A. Charlesworth,et al.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure. , 2000, Circulation.